Browse
Publications
Preprints
About
About UCL Open: Env.
Aims and Scope
Editorial Board
Indexing
APCs
How to cite
Publishing policies
Editorial policy
Peer review policy
Equality, Diversity & Inclusion
About UCL Press
Contact us
For authors
Information for authors
How it works
Benefits of publishing with us
Submit
How to submit
Preparing your manuscript
Article types
Open Data
ORCID
APCs
Contributor agreement
For reviewers
Information for reviewers
Review process
How to peer review
Peer review policy
My ScienceOpen
Sign in
Register
Dashboard
Search
Browse
Publications
Preprints
About
About UCL Open: Env.
Aims and Scope
Editorial Board
Indexing
APCs
How to cite
Publishing policies
Editorial policy
Peer review policy
Equality, Diversity & Inclusion
About UCL Press
Contact us
For authors
Information for authors
How it works
Benefits of publishing with us
Submit
How to submit
Preparing your manuscript
Article types
Open Data
ORCID
APCs
Contributor agreement
For reviewers
Information for reviewers
Review process
How to peer review
Peer review policy
My ScienceOpen
Sign in
Register
Dashboard
Search
419
publications
Top publications
315
views
Most viewed
0
reviews
Latest reviews
0
follows
Top followed users
0
followers
Follow
0
edited collections
All edited
0
followed collections
All followed
Publications
419
Four-year survival update for metastatic melanoma (MM) patients (pts) treated with ipilimumab (ipi) plus dacarbazine (DTIC) on Phase 3 study CA184-024
Authors:
M Maio
,
I. Bondarenko
,
C Robert
…
Real-world data for selixipag in patients with connective tissue disease-associated pulmonary arterial hypertension: a SPHERE (selexipag: the users drug reigistry) analysis
Authors:
K Chin
,
M Chakinala
,
A. Hemnes
…
Treatment patterns in pulmonary arterial hypertension: changes in clinical practice over time using real-world evidence from the combined OPUS/ORPHEUS data sets
Authors:
K Chin
,
R Channick
,
V. McLaughlin
…
All publications
Record
: found
Orcid
: not found
Profile
: not found
K Chin
Actions
Follow
New message
Share
Twitter
Sina Weibo
Facebook
Email
Statistics